Semmelweis Publications
  • Main page

    • Dank, Magdolna Semmelweis University affiliated publications (2021-2026)

    Year:
    Order by:
    Authorship:
    Number of publications: 58
    1.
    Machine learning prediction of breast cancer local recurrence localization, and distant metastasis after local recurrences
    Kovács, KA;Kerepesi, C;Rapcsák, D;Madaras, L;Nagy, A;Takács, A;Dank, M;Szentmártoni, G;Szász, AM;Kulka, J;Tokés, AM
    Q1
    SCIENTIFIC REPORTS
    2025.
    DOI:10.1038/s41598-025-89339-9 (Copy DOI)
    2.
    Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism
    Vékony, B;Nyiro, G;Herold, Z;Fekete, J;Ceccato, F;Gruber, S;Kürzinger, L;Parasiliti-Caprino, M;Bioletto, F;Szücs, N;Doros, A;Szeredás, BK;Nazri, SKSM;Fell, V;Bassiony, M;Dank, M;Azizan, EA;Bancos, I;Beuschlein, F;Igaz, P
    D1
    HYPERTENSION
    2024.
    DOI:10.1161/HYPERTENSIONAHA.124.23418 (Copy DOI)
    3.
    Hungarian consensus recommendation on the role of vitamin D in disease prevention and treatment
    Takács, I;Dank, M;Majnik, J;Nagy, G;Szabó, A;Szabó, B;Szekanecz, Z;Sziller, I;Toldy, E;Tislér, A;Valkusz, Z;Várbiró, S;Wikonkál, N;Lakatos, P
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32463 (Copy DOI)
    4.
    Effects of taxane-anthracycline and taxane only treatment on cardiac function in breast cancer-a retrospective cohort study
    Kézdi, A;Szelke, E;Dank, M;Mühl, D;Szentmártoni, G;Szabó, G;Fogarasi, DJ;Takács, I;Horváth, VJ;Tabák, AG
    Q2
    CARDIO-ONCOLOGY
    2025.
    DOI:10.1186/s40959-025-00335-4 (Copy DOI)
    5.
    A Liquid Biopsy-Based Approach for Monitoring Treatment Response in Post-Operative Colorectal Cancer Patients
    Barták, BK;Fodor, T;Kalmár, A;Nagy, ZB;Zsigrai, S;Szigeti, KA;Valcz, G;Igaz, P;Dank, M;Takács, I;Molnár, B
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2022.
    DOI:10.3390/ijms23073774 (Copy DOI)
    6.
    Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors
    Szentmartoni, G;Mühl, D;Csanda, R;Szasz, AM;Herold, Z;Dank, M
    Q1
    BIOMEDICINES
    2024.
    DOI:10.3390/biomedicines12030593 (Copy DOI)
    7.
    High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
    Herold, Z;Herold, M;Herczeg, G;Fodor, A;Szasz, AM;Dank, M;Somogyi, A
    WORLD JOURNAL OF CLINICAL CASES
    2022.
    DOI:10.12998/wjcc.v10.i13.4084 (Copy DOI)
    8.
    Surgical Treatment and Outcome of Ovarian Cancer Patients With Liver Metastases: Experience of a Tertiary Hepatic and Peritoneal Surface Malignancy Center
    Acs, M;Herold, Z;Neumann, L;Slowik, P;Evert, K;Gurok, S;Panczel, I;Barna, AJ;Dank, M;Szasz, AM;Hornung, M;Schlitt, HJ;Werner, JM
    Q2
    ANTICANCER RESEARCH
    2024.
    DOI:10.21873/anticanres.16864 (Copy DOI)
    9.
    Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020
    Kiss, Z;Kocsis, J;Nikolényi, A;Horváth, Z;Knollmajer, K;Benedek, A;Várnai, M;Polányi, Z;Kovács, KA;Berta, A;Köveskuti, I;Karamousouli, E;Szabó, TG;Rokszin, G;Fábián, I;Tamás, RB;Surján, O;Fürtos, D;Surján, G;Kenessey, I;Weber, A;Barcza, Z;Berki, T;Vokó, Z;Dózsa, C;Dank, M;Boér, K
    Q2
    FRONTIERS IN ONCOLOGY
    2023.
    DOI:10.3389/fonc.2023.1182170 (Copy DOI)
    10.
    Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
    Herold, Z;Herold, M;Lohinszky, J;Szasz, AM;Dank, M;Somogyi, A
    WORLD JOURNAL OF CLINICAL CASES
    2022.
    DOI:10.12998/wjcc.v10.i20.6825 (Copy DOI)
    11.
    The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
    Dank, M;Mühl, D;Pölhös, A;Csanda, R;Herold, M;Kovacs, AK;Madaras, L;Kulka, J;Palhazy, T;Tokes, AM;Toth, M;Ujhelyi, M;Szasz, AM;Herold, Z
    Q2
    GENES
    2023.
    DOI:10.3390/genes14091708 (Copy DOI)
    12.
    Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
    Steinhoff, H;Acs, M;Blaj, S;Dank, M;Herold, M;Herold, Z;Herzberg, J;Sanchez-Velazquez, P;Strate, T;Szasz, AM;Piso, P
    Q1
    WORLD JOURNAL OF GASTROENTEROLOGY
    2023.
    DOI:10.3748/wjg.v29.i18.2850 (Copy DOI)
    13.
    Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
    Rubovszky, G;Kocsis, J;Boer, K;Chilingirova, N;Dank, M;Kahan, Z;Kaidarova, D;Kover, E;Krakovska, BV;Mahr, K;Mrinakova, B;Piko, B;Bozovic-Spasojevic, I;Horvath, Z
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2022.
    DOI:10.3389/pore.2022.1610383 (Copy DOI)
    14.
    Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
    Dank, M;Mühl, D;Herold, M;Hornyák, L;Szasz, AM;Herold, Z
    Q1
    JOURNAL OF CLINICAL MEDICINE
    2022.
    DOI:10.3390/jcm11164815 (Copy DOI)
    15.
    The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary
    Vizin, G;Szekeres, T;Juhász, A;Márton, L;Dank, M;Perczel-Forintos, D;Urbán, R
    Q1
    BMC PSYCHOLOGY
    2023.
    DOI:10.1186/s40359-023-01355-4 (Copy DOI)
    16.
    Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden
    Bakos, B;Kiss, A;Arvai, K;Szili, B;Deák-Kocsis, B;Tobiás, B;Putz, Z;Armós, R;Balla, B;Kósa, J;Dank, M;Valkusz, Z;Takács, I;Tabák, A;Lakatos, P
    Q2
    BMC CANCER
    2021.
    DOI:10.1186/s12885-021-08377-4 (Copy DOI)
    17.
    Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
    Petenyi, FG;Garay, T;Muhl, D;Izso, B;Karaszi, A;Borbenyi, E;Herold, M;Herold, Z;Szasz, AM;Dank, M
    DISEASES
    2021.
    DOI:10.3390/diseases9040081 (Copy DOI)
    18.
    Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
    Kiss, E;Forika, G;Mohacsi, R;Nemeth, Z;Krenacs, T;Dank, M
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2021.
    DOI:10.3390/ijms22073598 (Copy DOI)
    19.
    Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
    Herold, Z;Szasz, AM;Dank, M
    Q2
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
    2021.
    DOI:10.4251/wjgo.v13.i9.1109 (Copy DOI)
    20.
    High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
    Barna, AJ;Herold, Z;Acs, M;Bazsa, S;Gajdacsi, J;Garay, TM;Herold, M;Madaras, L;Muhl, D;Nagy, A;Szasz, AM;Dank, M
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2023.
    DOI:10.3390/ijms241813684 (Copy DOI)
    21.
    Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
    Herold, M;Szasz, AM;Szentmartoni, G;Martinek, E;Madar-Dank, V;Barna, AJ;Mohacsi, R;Somogyi, A;Dank, M;Herold, Z
    D1
    SCIENTIFIC REPORTS
    2023.
    DOI:10.1038/s41598-023-40216-3 (Copy DOI)
    22.
    Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
    Herold, Z;Acs, M;Szasz, AM;Olasz, K;Hussong, J;Mayr, M;Dank, M;Piso, P
    Q1
    CANCERS
    2022.
    DOI:10.3390/cancers14163978 (Copy DOI)
    23.
    A case study of cognitive behavioral therapy for illness anxiety and depression caused COVID-19 in a breast cancer
    Tamás, S;Dora, PF;Magdolna, D;Gabriella, V
    Q4
    ORVOSI HETILAP
    2022.
    DOI:10.1556/650.2022.32510 (Copy DOI)
    24.
    Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
    Yamamoto, Y;Yamashiro, H;Schneeweiss, A;Mueller, V;Gluz, O;Klare, P;Aktas, B;Magdolna, D;Büdi, L;Pikó, B;Mangel, L;Toi, M;Morita, S;Ohno, S
    Q1
    BREAST CANCER
    2023.
    DOI:10.1007/s12282-022-01399-1 (Copy DOI)
    Semmelweis University authors: Dank, Magdolna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    25.
    Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
    Kleef, R;Dank, M;Herold, M;Agoston, EI;Lohinszky, J;Martinek, E;Herold, Z;Szasz, AM
    D1
    SCIENTIFIC REPORTS
    2023.
    DOI:10.1038/s41598-023-47802-5 (Copy DOI)
    26.
    Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
    Herczeg, G;Somogyi, A;Herold, M;Fodor, A;Rosta, K;Dank, M;Lang, Z;Herold, Z
    Q3
    OPEN MEDICINE
    2022.
    DOI:10.1515/med-2021-0407 (Copy DOI)
    27.
    Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
    Kiss, E;Forika, G;Dank, M;Krenacs, T;Nemeth, Z
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2022.
    DOI:10.3390/ijms23052546 (Copy DOI)
    28.
    Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2-Advanced Breast Cancer: A Nationwide Real-World Experience
    Boér, K;Rubovszky, G;Rokszin, G;Abonyi-Tóth, Z;Földesi, C;Dank, M
    Q2
    ONCOTARGETS AND THERAPY
    2021.
    DOI:10.2147/OTT.S309862 (Copy DOI)
    29.
    Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
    Szasz, AM;Alvarez, EEA;Fiorentini, G;Herold, M;Herold, Z;Sarti, D;Dank, M
    Q1
    CANCERS
    2023.
    DOI:10.3390/cancers15030880 (Copy DOI)
    30.
    Elektromágneses eljárások a hasnyálmirigyrák kezelésében: eminens vagy renitens?
    Dank, Magdolna; Herold, Magdolna; Garay, Tamás Márton; Gajdácsi, József; Herold, Zoltán; Szász, Attila Marcell;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2023.
    31.
    Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
    Agoston, EI;Acs, B;Herold, Z;Fekete, K;Kulka, J;Nagy, A;Mühl, D;Mohacsi, R;Dank, M;Garay, T;Harsanyi, L;Gyorffy, B;Szasz, AM
    Q2
    GENES
    2022.
    DOI:10.3390/genes13040589 (Copy DOI)
    32.
    Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
    Herold, Z;Dank, M;Herold, M;Nagy, P;Rosta, K;Somogyi, A
    Q1
    CANCERS
    2021.
    DOI:10.3390/cancers13010067 (Copy DOI)
    33.
    Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer
    Kiss, A;Szili, B;Bakos, B;Armós, R;Putz, Z;Arvai, K;Kocsis-Deák, B;Tobiás, B;Balla, B;Pikó, H;Dank, M;Kósa, JP;Takács, I;Lakatos, P
    Q2
    BMC ENDOCRINE DISORDERS
    2023.
    DOI:10.1186/s12902-023-01276-8 (Copy DOI)
    34.
    Longitudinal Analysis of 1α,25-dihidroxyvitamin D3 and Homocysteine Changes in Colorectal Cancer
    Muehl, D;Herold, M;Herold, Z;Hornyak, L;Szasz, AM;Dank, M
    Q1
    CANCERS
    2022.
    DOI:10.3390/cancers14030658 (Copy DOI)
    35.
    Immune Marker and C-Reactive Protein Dynamics and Their Prognostic Implications in Modulated Electro-Hyperthermia Treatment in Advanced Pancreatic Cancer: A Retrospective Analysis
    Dobos, NK;Garay, T;Herold, M;Simon, A;Madar-Dank, V;Balka, G;Gajdacsi, J;Dank, M;Szasz, AM;Herold, Z
    Q2
    IMMUNO
    2024.
    DOI:10.3390/immuno4040025 (Copy DOI)
    36.
    Impact of a Targeted Project for Shortening of Imaging Diagnostic Waiting Time in Patients with Suspected Oncological Diseases in Hungary
    Papp, ZM;Szakács, L;Hajivandi, SS;Kalina, I;Varga, E;Kiss, G;Solymos, F;Takács, I;Dank, M;Dudás, I;Szanka, T;Dózsa, CL;Rékassy, B;Merkely, B;Maurovich-Horvat, P
    Q2
    MEDICINA-LITHUANIA
    2023.
    DOI:10.3390/medicina59010153 (Copy DOI)
    37.
    Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells
    Németh, A;Bányai, GL;Dobos, NK;Kós, T;Gaál, A;Varga, Z;Buzás, EI;Khamari, D;Dank, M;Takács, I;Szász, AM;Garay, T
    D1
    CELL COMMUNICATION AND SIGNALING
    2024.
    DOI:10.1186/s12964-024-01660-4 (Copy DOI)
    38.
    The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary
    Kiss, E;Hajdu, A;Forika, G;Dank, M;Krenacs, T;Nemeth, Z
    Q1
    CANCERS
    2022.
    DOI:10.3390/cancers14184432 (Copy DOI)
    39.
    Heretumoros betegek termékenyítőképességének vizsgálata
    Martin, Tamás; Dank, Magdolna; Biró, Krisztina; Küronya, Zsófia; Gyergyay, Fruzsina; Nagyiványi, Krisztián; Budai, Barna; Fűrész, Katinka; Géczi, Lajos;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2021.
    Semmelweis University authors: Dank, Magdolna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    40.
    Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis
    Panczel, I;Acs, M;Herold, M;Madar-Dank, V;Piso, P;Schlitt, HJ;Dank, M;Szasz, AM;Herold, Z
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms25137495 (Copy DOI)
    41.
    Review of bone health in women receiving endocrine therapy because of breast cancer
    Kollár, R;Leel-Ossy, T;Pálffy, V;Dank, M;Horváth, C;Mészáros, S
    Q4
    ORVOSI HETILAP
    2024.
    DOI:10.1556/650.2024.33043 (Copy DOI)
    42.
    Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study
    Herold, Z;Herold, M;Szentmartoni, G;Szalasy, R;Lohinszky, J;Somogyi, A;Szasz, AM;Dank, M
    D1
    MEDICAL SCIENCES
    2025.
    DOI:10.3390/medsci13030108 (Copy DOI)
    43.
    How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions
    Kleiner, D;Haghverdi, F;Szépe, O;Horváth, IL;Sebok, S;Csupor, D;Horváth, A;Balogh, AG;Monostory, K;Kóbori, L;Balázs, M;Dank, M;Móczár, CM;Becze, A;Süle, A;Zelkó, R
    Q2
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY
    2025.
    DOI:10.1136/ejhpharm-2025-004478 (Copy DOI)
    44.
    Social framework to judge the importance of breast cancer
    Pozsár, ZR;Tóth, K;Moizs, M;Révész, J;Tatár-Kiss, K;Tittmann, J;Nikolényi, A;Kovács, AA;Mátrai, T;Szabó, BJ;Kovács, EH;Czene, C;Hosszú, D;Bögös, A;Nguyen, TT;Bartha, JZ;Agh, T;Kaló, Z;Dank, M
    Q1
    JOURNAL OF CANCER POLICY
    2026.
    DOI:10.1016/j.jcpo.2025.100679 (Copy DOI)
    45.
    Világossejtes vesesejtes karcinóma koroideális melanómát utánzó áttéte
    Tóth, Gábor; Hécz, Réka; Tóth, Jeannette; Pencz, Bianka; Szabó, Antal; Lukáts, Olga; Szűcs, Miklós; Dank, Magdolna; Nagy, Zoltán Zsolt; Csákány, Béla;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2022.
    46.
    Primer prevenció, kardiovaszkuláris rizikó optimalizáció daganatos betegekben: az életmód és a gyógyszeres terápia szerepe
    Juhász, Ágnes; Hajdú, Anett; Dank, Magdolna;
    CARDIOLOGIA HUNGARICA 0133-5596 1588-0230
    2023.
    DOI:10.26430/CHUNGARICA.2023.53.2.144 (Copy DOI)
    47.
    Daganatos betegek fizioterápiája - narratív összefoglaló és szakértői vélemény
    Bender, Tamás; Szekanecz, Éva; Gomez, Izabella; Péntek, Irén; Maráz, Anikó; Dank, Magdolna; Szekanecz, Zoltán;
    Q4
    MAGYAR ONKOLÓGIA 0025-0244 2060-0399
    2025.
    48.
    „Chemobrain”
    Szekeres, Tamas; Dank, Magdolna; Szentmartoni, Gyongyver; Virag, Marta;
    Q2
    NEUROPSYCHOPHARMACOLOGIA HUNGARICA 1419-8711 2064-2512
    2025.
    49.
    Ultra-processed foods and dietary habits of oncology patients: Risk factor or survival strategy
    Madarasz, B;Balazs, MA;Palfi, E;Konczos, J;Toth, A;Szentmartoni, G;Herold, Z;Dank, M
    WORLD JOURNAL OF CLINICAL ONCOLOGY
    2025.
    DOI:10.5306/wjco.v16.i12.111372 (Copy DOI)
    50.
    Complex treatment of hepatocellular carcinoma Consensus Conference, Budapest, April 24, 2021
    Hahn, O;Szijárto, A;Pekli, D;Fülöp, A;Kokas, B;Bárdos, D;András, C;Bartek, P;Battyáni, I;Bezsilla, J;Bodoky, G;Bursics, A;Dank, M;Dankovics, Z;Deák, PA;Dede, K;Demeter, G;Doros, A;Dudas, I;Egyed, Z;Farkas, R;Gerlei, Z;Györke, T;Hagymási, K;Hahn, O;Hitre, E;Hohn, J;Jancsik, V;Káposztas, Z;Király, I;Lóderer, TM;Nagy, E;Oláh, A;Pajor, P;Papp, A;Pár, G;Patyánik, M;Pekli, D;Petrányi, A;Petri, A;Piros, L;Schuller, J;Sikorszki, L;Szabó, J;Székely, E;Szombati, A;Torday, L;Toth, J;Tóth...
    ORVOSI HETILAP
    2021.
    DOI:10.1556/650.2021.32431 (Copy DOI)
    Semmelweis University authors: Hahn, Oszkár, Szijártó, Attila, Pekli, Damján, Fülöp, András, Kokas, Bálint András, Bárdos, Dávid, Dank, Magdolna, Deák, Pál Ákos, Doros, Attila, Dudás, Ibolyka, Gerlei, Zsuzsanna, Györke, Tamás, Hagymási, Krisztina, Petrányi, Ágota Eszter, Piros, László, Székely, Eszter, Dósa, Edit, Harsányi, László, Lengyel, Gabriella, Maurovich-Horvat, Pál, Nemes, Balázs, Schaff, Zsuzsa, Szalay, Ferenc, Szűcs, Ákos,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Patológiai, Igazságügyi és Biztosítási Orvostani Intézet, Department of Internal Medicine and Oncology, Orvosi Képalkotó Klinika, Sebészeti, Transzplantációs és Gasztroenterológiai Klinika, Cardiovascular Center, II. Department of Pathology, II. Department of Surgery,
    51.
    Telerehabilitáció az onkológiában
    Juhász, Ágnes; Hajdú, Anett; Dank, Magdolna;
    IME 1588-6387 1789-9974
    2021.
    DOI:10.53020/IME-2021-305 (Copy DOI)
    Semmelweis University authors: Dank, Magdolna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    52.
    B Vitamin Intake and the Risk of Colorectal Cancer Development: A Systematic Review and Meta-Analysis of Observational Studies
    Kiss, Eva; Muhl, Dorottya; Mohacsi, Reka; Dank, Magdolna; Takacs, Istvan; Nemeth, Zsuzsanna;
    BIOMEDICAL JOURNAL OF SCIENTIFIC AND TECHNICAL RESEARCH 2574-1241
    2022.
    DOI:10.26717/BJSTR.2022.40.006516 (Copy DOI)
    53.
    Gyógyszerbiztonsági szemelvények - A múlt tanulságai és a jövő lehetőségei
    Balázs, Máté Ádám; Dank, Magdolna;
    KLINIKAI ONKOLÓGIA 2064-5058 2498-8596
    2024.
    54.
    Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting
    Balmaña, Judith; Fasching, Peter A; Couch, Fergus J; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F; You, Benoit; Bourgeois, Hughes; Gonçalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V; Park-Simon, Tjoung-Won; Antón-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A; Koynova, Tatyana; , ; Popov, Vasil; Ti...
    Q1
    BREAST CANCER RESEARCH AND TREATMENT 0167-6806 1573-7217
    2024.
    DOI:10.1007/s10549-023-07165-x (Copy DOI)
    Semmelweis University authors: Boér, Katalin, Dank, Magdolna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    55.
    Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
    Bardia, Aditya; Hu, Xichun; Dent, Rebecca; Yonemori, Kan; Barrios, Carlos H; O'Shaughnessy, Joyce A; Wildiers, Hans; Pierga, Jean-Yves; Zhang, Qingyuan; Saura, Cristina; Biganzoli, Laura; Sohn, Joohyuk; Im, Seock-Ah; Lévy, Christelle; Jacot, William; Begbie, Natasha; Ke, Jun; Patel, Gargi; Curigliano, Giuseppe; Streich, Guillermo; , ; Cundom, Juan; Constanzo, Maria Victoria; Casarini, Ignacio; Casalnuovo, Monica; Daniele, Sergio; Ostoich, Sandra Anabel; Escudero, Miguel; Palazzo, Felipe; Bella,...
    D1
    NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 1533-4406
    2024.
    DOI:10.1056/NEJMoa2407086 (Copy DOI)
    Semmelweis University authors: Dank, Magdolna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    56.
    A daganatos betegek vénás tromboembóliájának kezelése
    Pálffy, Veronika; Kovács, Mónika Gabriella; Szentmártoni, Gyöngyvér; Dank, Magdolna;
    ORVOSTOVÁBBKÉPZŐ SZEMLE 1218-2583
    2024.
    57.
    Pszichoonkológiai intervenciók – bizonyítékokon alapuló pszichoterápiás ellátás krónikus testi betegségekben
    Szekeres, Tamás; Dank, Magdolna; Vizin, Gabriella;
    ORVOSKÉPZÉS 0030-6037
    2024.
    58.
    Daganatmegelőzés VB, avagy a változtatható betegségkockázatok öt kiemelt tényezője
    Schwab, Richárd; Bodoky, György; Kempler, Péter; Frecska, Ede; Várdi, Katalin; Dank, Magdolna;
    KLINIKAI ONKOLÓGIA 2064-5058 2498-8596
    2025.

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2026_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 10.02.2025
    (c) Semmelweis University - Central Library